CommercialCoverageMedium impact
Magnetic Resonance Imaging-Targeted Biopsy of the Prostate
Blue Cross & Blue Shield of Mississippi·MS · Urology, Radiology, Oncology·Medical Policy
We identified it
Jun 20, 2026
Summary
BCBS Mississippi now considers MRI-targeted biopsy of the prostate medically necessary for diagnosis and active surveillance of prostate cancer. This represents a new coverage policy that may affect billing and prior authorization requirements for prostate MRI-guided biopsies.
Action Required
Immediately: Billing team should verify current prior authorization requirements for MRI-targeted prostate biopsies with BCBS Mississippi, as this new coverage policy may change existing approval processes. Update billing guidelines to reflect that these procedures are now considered medically necessary for diagnosis and active surveillance of prostate cancer. Contact BCBS Mississippi to confirm specific billing requirements and documentation needs.